This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pain  • End-of-life Care/ Palliative Medicine  • Neoplasms  • Alert me on articles by topic

Beata LeBon, MRCP; Teresa A. Beynon, MD, FRCP; Sean J. Whittaker, MD, FRCP

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The skin is the second most common site of extranodal non-Hodgkin lymphomas, most of which are mycosis fungoides.¹ Currently available treatments such as skin-directed therapies, bioimmunotherapies, and chemotherapy are usually associated with only short-lived responses.¹ There is a general trend toward a palliative approach to treatment from an early stage in the disease.²

Although quality of life assessment tools in primary cutaneous lymphoma (PCL) have been evaluated,³ to our knowledge there have been no publications on the experiences and needs of patients with PCL as they approach the end of life or on the scope for palliative care. To explore this subject, a retrospective palliative care case note review was carried out by the palliative care team based at the national treatment center for PCL in England. The objectives of this study were to describe the perceived . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION